[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.176.189. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Viewpoint
June 2018

Clinical Trials in Medical Center Advertising

Author Affiliations
  • 1Department of Philosophy, Center for Ethics and Policy, Carnegie Mellon University, Pittsburgh, Pennsylvania
  • 2Studies of Translation, Ethics, and Medicine, Biomedical Ethics Unit, McGill University, Montréal, Quebec, Canada
JAMA Oncol. 2018;4(6):769-770. doi:10.1001/jamaoncol.2018.0181

Many well-established medical centers advertise the opportunity for clinical trial participation to suggest that they offer patients a therapeutic edge. A billboard for Georgia Cancer Center reads “Clinical Trials: Another Reason to See Us First” (https://jagwire.augusta.edu/archives/39855). A Johns Hopkins video encourages patients to participate in such trials, because “[they] open up new treatments that [patients] otherwise would not have available to them” (https://www.youtube.com/watch?v=8ZKjQa4gFeQ&feature=c4-overview-vl&list=PL0A17443C77172961). Cancer Treatment Centers of America states that it “offers clinical trials as part of our commitment to bringing our patients new and innovative cancer treatment options…” (http://www.cancercenter.com/clinical-trials/).

×